CTRI/2023/06/054116已完成3 期
An Open, Non-Randomized, Single arm, Single centricClinical trial to determine the effectiveness of Wound dressing with Punga Thailam in the management of Madhumega viranam (Diabetic Foot Ulcer)
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Outcome will be measured with the use of leg ulcer measurement tool.
研究概览
简要总结
It is an open non randomized, single arm, single centric, trail to determine the therapeutic effectiveness of punga thailam in the management of madhumega viranam (diabetic foot ulcer). Patients with diabetic foot ulcers will be enrolled for the study as per inclusion and exclusion criteria. After the enrollment, treatment will be given with punga thailam. Regular wound dressing will be done, and the ulcer will be assessed weekly with the use of leg ulcer measurement tool.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 18.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •Age: >18 years Sex: Male, Female and Transgender Superficial ulcer, Destruction of the thickness of the skin/ Penetrates through skin not affecting bone (Wagner’s Classification I & II) Willing to give specimen of blood for the investigation.
- •Willing to take photograph.
- •Willing to participate in trial by signing the informed consent.
- •Good control of Diabetes Mellitus.
排除标准
- •Ischemic foot Deep Ulcer (cellulitis) / Osteomyelitis with Ulceration or abscess/ Gangrenous patches limited to toes or part of the foot/ Gangrene of the entire foot (Wagner’s classification II, III, IV & V) Varicose ulcer Hansen’s disease Tuberculous ulcer Any active neoplastic disease Necrotizing fasciitis The patient who has uncontrolled diabetes will be treated for diabetes mellitus and after that he/she will be included for this study.
结局指标
主要结局
Outcome will be measured with the use of leg ulcer measurement tool.
时间窗: 12 months
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
A Clinical Trail of Venkara Parpam for Neerkattu Vatham (Benign Prostatic Hyperplasia)CTRI/2022/07/044050National Institute of Siddha25
尚未招募
不适用
Safety and Efficacy of Dysmegesic in the management of Menstrual Pain in Female Subjects.CTRI/2021/01/030354Shield Healthcare Pvt Ltd120
Unknown
2 期
Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)Small Cell Lung CancerNCT02995187Chinese Academy of Medical Sciences25
尚未招募
2 期
Gandhaga Mezhugu for treating Urinaray infectionCTRI/2023/09/057245National Institute of Siddha10
Unknown
2 期
XLCART001 Treatment in Relapsed/Refractory/High-risk B-cell Malignancy SubjectsLymphoma, B-CellLeukemia, B-cellNCT03598179The First Affiliated Hospital with Nanjing Medical University10